Quantcast
Environmental News for a Healthier Planet and Life

Trump EPA Ignored Its Own Scientists' Calls to Ban Asbestos, 'Bombshell' Report Shows

Health + Wellness
Bronwyn8 / iStock / Getty Images Plus

By Jessica Corbett

In a report that elicited calls for congressional action, The New York Times revealed Wednesday that "senior officials at the Environmental Protection Agency disregarded the advice of their own scientists and lawyers in April when the agency issued a rule that restricted but did not ban asbestos."


Asbestos is a group of fibrous, heat-resistant minerals used in manufactured goods, particularly building materials. According to the World Health Organization, "All types of asbestos cause lung cancer, mesothelioma, cancer of the larynx and ovary, and asbestosis (fibrosis of the lungs)."

EPA Administrator Andrew Wheeler said in a statement last month that the agency's new rule "gives us unprecedented authorities to protect public health" and block certain products from the market. However, environmental and public health advocates raised concerns at the time about loopholes that remain, with one critic calling the regulation "toothless."

Criticism of the rule resurfaced Wednesday when the Times reported on a pair of internal EPA memos from last August, in which more than a dozen agency experts wrote:

Rather than allow for (even with restrictions) any new uses for asbestos, EPA should seek to ban all new uses of asbestos because the extreme harm from this chemical substance outweighs any benefit — and because there are adequate alternatives to asbestos.

Melanie Benesh, legislative attorney at the Environmental Working Group (EWG), was among those who demanded action from federal lawmakers following the "bombshell" report.

"The sheer number of lives cut short and families destroyed from asbestos exposure demand nothing less than an outright ban," Benesh said in a statement. "I can't think of an easier vote for members of Congress to cast than for a bill that bans a substance responsible for the deaths of so many."

The reporting came as a subcommittee of the U.S. House Committee on Energy and Commerce held a hearing Wednesday morning to consider legislation that would amend the Toxic Substances Control Act (TSCA) "to prohibit the manufacture, processing, and distribution in commerce of asbestos and asbestos-containing mixtures and articles."

"If Administrator Wheeler and the Trump administration won't act," said Benesh, "then Congress must by passing this critical piece of legislation that finally bans asbestos."

Sharing a link to the Times article on Twitter, Rep. Frank Pallone Jr. (D-N.J.), the committee's chairman, said, "This is exactly why we need to ban asbestos and why my committee is holding a hearing today on legislation that would fully ban this toxic material."

During the committee hearing, Pallone noted that it has been 40 years since the EPA started its work to ban asbestos under the TSCA, 30 years since the agency finalized its ban, and 28 years since the ban was struck down in court — and yet, "asbestos is still being imported into the United States, it is still being used in this country, and it is still killing about 40,000 Americans every year."

"Twenty-eight years of frustration, of sickness, and loss," he said. "We have known the dangers of asbestos for decades. Enough is enough."

The hearing centered on H.R. 1603 — also known as the Alan Reinstein Ban Asbestos Now Act of 2019. Rep. Suzanne Bonamici (D-Ore.), the bill's sponsor, took to Twitter Wednesday to highlight a testimony from the widow of the legislation's namesake.

After Alan Reinstein was diagnosed with mesothelioma in 2003, Linda Reinstein and Doug Larkin co-founded the Asbestos Disease Awareness Organization (ADAO). Alan Reinstein and Larkin both died in the years that followed, but Linda Reinstein remains ADAO's president and CEO.

"I'm honored to have H.R. 1603 named after my husband," Linda Reinstein told lawmakers Wednesday, "but it's really for the hundreds of thousands of Alans who have paid a price for this man-made disaster with their lives."

Reposted with permission from our media associate Common Dreams.

EcoWatch Daily Newsletter

The Ernest N. Morial Convention Center in New Orleans, Louisiana has been converted to a 1,000-bed field hospital for coronavirus patients to alleviate stress on local hospitals. Chris Graythen / Getty Images

An area in Louisiana whose predominantly black and brown residents are hard-hit by health problems from industry overdevelopment is experiencing one of the highest death rates from coronavirus of any county in the United States.

Read More Show Less
A woman lies in bed with the flu. marka/Universal Images Group via Getty Images

A central player in the fight against the novel coronavirus is our immune system. It protects us against the invader and can even be helpful for its therapy. But sometimes it can turn against us.

Read More Show Less
Sponsored
Several flower species, including the orchid, can recover quickly from severe injury, scientists have found. cunfek / iStock / Getty Images Plus

Calling someone a delicate flower may not sting like it used to, according to new research. Scientists have found that many delicate flowers are actually remarkably hearty and able to bounce back from severe injury.

Read More Show Less
A Boeing 727 flies over approach lights with a trail of black-smoke from the engines on April 9, 2018. aviation-images.com / Universal Images Group via Getty Images

With global air travel at a near standstill, the airline industry is looking to rewrite the rules it agreed to tackle global emissions. The Guardian reports that the airline is billing it as a matter of survival, while environmental activists are accusing the industry of trying to dodge their obligations.

Read More Show Less
A National Guard member works on election day at a polling location on April 7, 2020 in Madison, Wisconsin. Andy Manis / Getty Images.

ByJulia Baumel

The outbreak of COVID-19 across the U.S. has touched every facet of our society, and our democracy has been no exception.

Read More Show Less